Lupin’s Mandideep Unit II Facility Receives EIR from US FDA
The inspection at the facility was carried out by the US FDA between November 26, 2018 and December 4, 2018
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Mandideep facility
Lupin gets warning letter from US FDA for Mandideep facility
Lupin said there are no drug master file and abbreviated new drug applications (ANDA) pending review or approval from the…